Pier Capital, LLC Neuronetics, Inc. Transaction History

Pier Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$9.0 - $17.2 $2.79 Million - $5.34 Million	-310,375 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$13.6 - $19.58 $480,610 - $691,937	35,339 Added 12.85%	310,375 $4.73 Million
Q4 2018 Feb 13, 2019	BUY	$16.0 - $31.84 $1.41 Million - $2.81 Million	88,216 Added 47.22%	275,036 $5.32 Million
Q3 2018 Nov 14, 2018	BUY	$24.32 - $37.54 $4.37 Million - $6.75 Million	179,820 Added 2568.86%	186,820 $5.99 Million
Q2 2018 Aug 08, 2018	BUY	$26.61 - $27.78 $186,270 - $194,460	7,000 New	7,000 $186,000

13M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $82.1M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pier Capital, LLC with notifications on news.